Our Portfolio
We have invested in 90+ companies across all industries and are growing.
We have invested in 90+ companies across all industries and are growing.
Verge Genomics is dedicated to using algorithms to further drug discovery for complex neurodegenerative conditions, including dementia, Alzheimer’s, and Parkinson’s disease. All of these conditions are currently without a cure, and they are estimated to cost society close to $1 trillion per year by 2020. Brain diseases are notoriously difficult to treat because they are caused by complex interactions between many genes—requiring a more advanced process than drug discovery techniques targeting a single gene at a time.
